Ann Griswold
Science writer
From this contributor
Sex and other foreign words
People with autism fall in love. They marry. They even (gasp) have sex. Yet these deeply human needs have mostly gone ignored by scientists.
Many people with harmful genetic variants show no ill effects
Most adults with genetic variants tied to certain conditions, such as heart disease or cancer, go undiagnosed.
Many people with harmful genetic variants show no ill effects
This is a story of autism in small-town America
Rural living can be wonderful: community, friendly faces, a slower pace of life. But when there’s autism in the family, it can be tough.
This is a story of autism in small-town America
Autism, fragile X follow different developmental paths
Children with autism show an increase in restricted interests in their preteen years that is not seen in those with fragile X syndrome.
Autism, fragile X follow different developmental paths
Autism gene may double as pain processor
SHANK3, a leading candidate gene for autism, helps sensory neurons in mice respond to pain.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.